Abstract
Globally chronic kidney (CKD) disease is one of the major health problems. Global prevalence of CKD is 8−16%. Prevalence of chronic kidney disease in Bangladesh is 26%. Patients with chronic kidney disease (CKD) exhibit significant alterations in lipoprotein metabolism. In this review different lipid parameters are shown from different studies and the pathogenesis of CKD induced dyslipidemia is discussed.
 Bangladesh J Med Biochem 2019; 12(2): 31-38
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
